共 50 条
- [41] Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T CellsCANCER CELL, 2019, 35 (02) : 221 - +Du, Hongwei论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USAHirabayashi, Koichi论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USAAhn, Sarah论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USAKren, Nancy Porterfield论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USAMontgomery, Stephanie Ann论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USAWang, Xinhui论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USATiruthani, Karthik论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USAMirlekar, Bhalchandra论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USAMichaud, Daniel论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USAGreene, Kevin论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USAHerrera, Silvia Gabriela论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USAXu, Yang论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USASun, Chuang论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USAChen, Yuhui论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USAMa, Xingcong论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USAFerrone, Cristina Rosa论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USAPylayeva-Gupta, Yuliya论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USAYeh, Jen Jen论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USALiu, Rihe论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USASavoldo, Barbara论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USAFerrone, Soldano论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USADotti, Gianpietro论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
- [42] Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1-CH3 fusion proteinCANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (10) : 1621 - 1634Pan, Zeyan论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R China Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R ChinaDi, Shengmeng论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R China Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R ChinaShi, Bizhi论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R China Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R ChinaJiang, Hua论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R China Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R ChinaShi, Zhimin论文数: 0 引用数: 0 h-index: 0机构: CARsgen Therapeut, Shanghai, Peoples R China Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R ChinaLiu, Ying论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R China Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R ChinaWang, Yi论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R China Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R ChinaLuo, Hong论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R China Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R ChinaYu, Min论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R China Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R ChinaWu, Xiuqi论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R China Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R ChinaLi, Zonghai论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R China CARsgen Therapeut, Shanghai, Peoples R China Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, 25 Ln 2200,XieTu Rd, Shanghai 200032, Peoples R China
- [43] NKT Cells Co-Expressing a GD2-Specific Chimeric Antigen Receptor and IL-15 Show Enhancedin Vivopersistence and Antitumor Activity Against NeuroblastomaMOLECULAR THERAPY, 2019, 27 (04) : 174 - 174Xu, Xin论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Houston, TX 77030 USA Baylor Coll Med, Houston, TX 77030 USAHuang, Wei论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Houston, TX 77030 USA Baylor Coll Med, Houston, TX 77030 USAHeczey, Andras论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Sect Hematol & Oncol, Pediat, Houston, TX 77030 USA Baylor Coll Med, Houston, TX 77030 USALiu, Daofeng论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Houston, TX 77030 USA Baylor Coll Med, Houston, TX 77030 USAGuo, Linjie论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Houston, TX 77030 USA Baylor Coll Med, Houston, TX 77030 USAWood, Micheal论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Houston, TX 77030 USA Baylor Coll Med, Houston, TX 77030 USAJin, Jinglin论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Houston, TX 77030 USA Baylor Coll Med, Houston, TX 77030 USACourtney, Amy论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Houston, TX 77030 USA Baylor Coll Med, Houston, TX 77030 USALiu, Bin论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Houston, TX 77030 USA Baylor Coll Med, Houston, TX 77030 USADiPiero, Erica论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Houston, TX 77030 USA Baylor Coll Med, Houston, TX 77030 USAHicks, John论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Houston, TX 77030 USA Baylor Coll Med, Houston, TX 77030 USABarragan, Gabriel论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Houston, TX 77030 USA Baylor Coll Med, Houston, TX 77030 USASavoldo, Barbara论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Chapel Hill, NC 27515 USA Baylor Coll Med, Houston, TX 77030 USADotti, Gianpietro论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Chapel Hill, NC 27515 USA Baylor Coll Med, Houston, TX 77030 USAMetelitsa, Leonid论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Houston, TX 77030 USA Baylor Coll Med, Houston, TX 77030 USA
- [44] Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion proteinCancer Immunology, Immunotherapy, 2018, 67 : 1621 - 1634Zeyan Pan论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiaotong University School of Medicine,State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji HospitalShengmeng Di论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiaotong University School of Medicine,State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji HospitalBizhi Shi论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiaotong University School of Medicine,State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji HospitalHua Jiang论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiaotong University School of Medicine,State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji HospitalZhimin Shi论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiaotong University School of Medicine,State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji HospitalYing Liu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiaotong University School of Medicine,State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji HospitalYi Wang论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiaotong University School of Medicine,State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji HospitalHong Luo论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiaotong University School of Medicine,State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji HospitalMin Yu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiaotong University School of Medicine,State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji HospitalXiuqi Wu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiaotong University School of Medicine,State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji HospitalZonghai Li论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiaotong University School of Medicine,State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital
- [45] Human T cells engineered with an HLA-A2-restricted murine T-cell receptor targeting glypican 3 effectively control human hepatocellular carcinoma in miceHEPATOLOGY, 2024,Vercher, Enric论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainCovo-Vergara, Angela论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainConde, Enrique论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainHernandez-Rueda, Mercedes论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainElizalde, Edurne论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainMancheno, Uxua论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainGlez-Vaz, Javier论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainTamayo-Uria, Ibon论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainGarcia-Garcia, Maritza R.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Autonomous Univ Guadalajara, Sch Med, Guadalajara, Jalisco, Mexico Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainFerrer-Roig, Marta论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainMaranon-Lopez, Javier论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainReparaz, David论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainRuiz, Marta论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spainde Cerio, Ascension Lopez-Diaz论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Clin Univ Navarra, Cell Therapy Area, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainInoges, Susana论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Clin Univ Navarra, Cell Therapy Area, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainInarrairaegui, Mercedes论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Clin Univ Navarra, Liver Unit, Pamplona, Spain Ctr Invest Biomed Red Enfermedades Hepat & Digest, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainLasarte, Juan J.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainSangro, Bruno论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Clin Univ Navarra, Liver Unit, Pamplona, Spain Ctr Invest Biomed Red Enfermedades Hepat & Digest, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainSarobe, Pablo论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Ctr Invest Biomed Red Enfermedades Hepat & Digest, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, SpainHervas-Stubbs, Sandra论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain Canc Clin Univ Navarra CCUN, Pamplona, Spain Ctr Invest Biomed Red Enfermedades Hepat & Digest, Pamplona, Spain Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Ave Pio 12 55, Pamplona 31008, Navarra, Spain
- [46] Enhanced cytotoxicity against cholangiocarcinoma by fifth-generation chimeric antigen receptor T cells targeting integrin αvβ6 and secreting anti-PD-L1 scFvJournal of Translational Medicine, 23 (1)Nattaporn Phanthaphol论文数: 0 引用数: 0 h-index: 0机构: Mahidol University,Department of Immunology, Faculty of Medicine Siriraj Hospital Mahidol University,Department of Immunology, Faculty of Medicine Siriraj HospitalChalermchai Somboonpatarakun论文数: 0 引用数: 0 h-index: 0机构: Mahidol University,Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE Mahidol University,Department of Immunology, Faculty of Medicine Siriraj HospitalKwanpirom Suwanchiwasiri论文数: 0 引用数: 0 h-index: 0机构: Mahidol University,Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE Mahidol University,Department of Immunology, Faculty of Medicine Siriraj HospitalPornpimon Yuti论文数: 0 引用数: 0 h-index: 0机构: Mahidol University,CIT), Research Department, Faculty of Medicine Siriraj Hospital Mahidol University,Department of Immunology, Faculty of Medicine Siriraj HospitalJatuporn Sujjitjoon论文数: 0 引用数: 0 h-index: 0机构: Mahidol University,Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE Mahidol University,Department of Immunology, Faculty of Medicine Siriraj HospitalPunn Augsornworawat论文数: 0 引用数: 0 h-index: 0机构: Mahidol University,CIT), Research Department, Faculty of Medicine Siriraj Hospital Mahidol University,Department of Immunology, Faculty of Medicine Siriraj HospitalGeorge S. Baillie论文数: 0 引用数: 0 h-index: 0机构: Mahidol University,Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE Mahidol University,Department of Immunology, Faculty of Medicine Siriraj HospitalMutita Junking论文数: 0 引用数: 0 h-index: 0机构: Mahidol University,CIT), Research Department, Faculty of Medicine Siriraj Hospital Mahidol University,Department of Immunology, Faculty of Medicine Siriraj HospitalPa-thai Yenchitsomanus论文数: 0 引用数: 0 h-index: 0机构: Mahidol University,Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE Mahidol University,Department of Immunology, Faculty of Medicine Siriraj Hospital
- [47] Chimeric Antigen Receptor T Cells Targeting NKG2D-Ligands Show Robust Efficacy Against Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic LeukemiaFRONTIERS IN IMMUNOLOGY, 2020, 11Driouk, Lina论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USAGicobi, Joanina K.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USAKamihara, Yusuke论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USARutherford, Kayleigh论文数: 0 引用数: 0 h-index: 0机构: Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USADranoff, Glenn论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, Cambridge, MA USA Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA论文数: 引用数: h-index:机构:Baumeister, Susanne H. C.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA Harvard Med Sch, Boston, MA 02115 USA Dana Farber Canc Inst, Div Pediat Oncol, Boston, MA 02115 USA Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA
- [48] Chimeric Antigen Receptor T Cells Targeting NKG2D-Ligands Show Robust Efficacy Against Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic LeukemiaBLOOD, 2019, 134Driouk, Lina论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USAGicobi, Joanina论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USAKamihara, Yusuke论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USARutherford, Kayleigh论文数: 0 引用数: 0 h-index: 0机构: Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USADranoff, Glenn论文数: 0 引用数: 0 h-index: 0机构: Novartis BioMed Inst, Cambridge, MA USA Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA论文数: 引用数: h-index:机构:Baumeister, Susanne H. C.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA Harvard Med Sch, Boston, MA 02115 USA Childrens Hosp Boston, Div Pediat Oncol, Dana Farber Canc Inst, Boston, MA USA Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA USA Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA
- [49] T cells expressing a LMP1-specific chimeric antigen receptor mediate antitumor effects against LMP1-positive nasopharyngeal carcinoma cells in vitro and in vivoJOURNAL OF BIOMEDICAL RESEARCH, 2014, 28 (06): : 468 - 475Tang, Xiaojun论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Dept Pathol, Nanjing 210029, Jiangsu, Peoples R China Nanjing Med Univ, Minist Hlth, Key Lab Antibody Tech, Nanjing 210029, Jiangsu, Peoples R China Nanjing Med Univ, Dept Pathol, Nanjing 210029, Jiangsu, Peoples R ChinaZhou, Yan论文数: 0 引用数: 0 h-index: 0机构: Ao Yang Hosp, Dept Oncol, Zhangjiagang 215617, Jiangsu, Peoples R China Nanjing Med Univ, Dept Pathol, Nanjing 210029, Jiangsu, Peoples R ChinaLi, Wenjie论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 2, Dept Otolaryngol, Nanjing 210011, Jiangsu, Peoples R China Nanjing Med Univ, Dept Pathol, Nanjing 210029, Jiangsu, Peoples R ChinaTang, Qi论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Minist Hlth, Key Lab Antibody Tech, Nanjing 210029, Jiangsu, Peoples R China Nanjing Med Univ, Dept Pathol, Nanjing 210029, Jiangsu, Peoples R ChinaChen, Renjie论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 2, Dept Otolaryngol, Nanjing 210011, Jiangsu, Peoples R China Nanjing Med Univ, Dept Pathol, Nanjing 210029, Jiangsu, Peoples R ChinaZhu, Jin论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Minist Hlth, Key Lab Antibody Tech, Nanjing 210029, Jiangsu, Peoples R China Huadong Med Inst Biotechn, Nanjing 210002, Jiangsu, Peoples R China Nanjing Med Univ, Dept Pathol, Nanjing 210029, Jiangsu, Peoples R ChinaFeng, Zhenqing论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Dept Pathol, Nanjing 210029, Jiangsu, Peoples R China Nanjing Med Univ, Minist Hlth, Key Lab Antibody Tech, Nanjing 210029, Jiangsu, Peoples R China Nanjing Med Univ, Canc Ctr, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing 210029, Jiangsu, Peoples R China Nanjing Med Univ, Dept Pathol, Nanjing 210029, Jiangsu, Peoples R China
- [50] T cells expressing a LMP1-specific chimeric antigen receptor mediate antitumor effects against LMP1-positive nasopharyngeal carcinoma cells in vitro and in vivoThe Journal of Biomedical Research, 2014, 28 (06) : 468 - 475Xiaojun Tang论文数: 0 引用数: 0 h-index: 0机构: Department of Pathology,Nanjing Medical University The Key Laboratory of Antibody Technique of Ministry of Health,Nanjing Medical University Department of Pathology,Nanjing Medical UniversityYan Zhou论文数: 0 引用数: 0 h-index: 0机构: Department of Oncology,Ao Yang Hospital Department of Pathology,Nanjing Medical UniversityWenjie Li论文数: 0 引用数: 0 h-index: 0机构: Department of Otolaryngological,The Second Affiliated Hospital of Nanjing Medical University Department of Pathology,Nanjing Medical UniversityQi Tang论文数: 0 引用数: 0 h-index: 0机构: The Key Laboratory of Antibody Technique of Ministry of Health,Nanjing Medical University Department of Pathology,Nanjing Medical UniversityRenjie Chen论文数: 0 引用数: 0 h-index: 0机构: Department of Otolaryngological,The Second Affiliated Hospital of Nanjing Medical University Department of Pathology,Nanjing Medical UniversityJin Zhu论文数: 0 引用数: 0 h-index: 0机构: The Key Laboratory of Antibody Technique of Ministry of Health,Nanjing Medical University Huadong Medical Institute of Biotechniques Department of Pathology,Nanjing Medical UniversityZhenqing Feng论文数: 0 引用数: 0 h-index: 0机构: Department of Pathology,Nanjing Medical University The Key Laboratory of Antibody Technique of Ministry of Health,Nanjing Medical University Jiangsu Key Lab of Cancer Biomarkers,Prevention and Treatment,Cancer Center,Nanjing Medical University Department of Pathology,Nanjing Medical University